Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients

NCT01496339 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

BIOLOGICAL: MenSCs transplantation
DRUG: exogenous indulin injection daily

Sponsor

S-Evans Biosciences Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]